Livzon Pharmaceuticals (01513) issued an announcement. Livzon Pharmaceuticals Group Co., Ltd. (hereinafter referred to as the “Company”) announced on 20...
Zhitong Finance App News, Lizhu Pharmaceutical (01513) issued an announcement. Livzon Pharmaceutical Group Co., Ltd. (hereinafter referred to as the “Company”) held the 19th meeting of the 11th board of directors and the 10th meeting of the 11th board of supervisors on September 27, 2024 to review and pass the “Proposal on Finalizing Capital Raising Investment Projects and Raising Savings Funds to Permanently Replenish Liquidity”, agreeing that the company will raise capital for investment projects (including the “Advanced Development and Industrialization Upgrade Project of the Iprazole Series of Innovative Products” and “The Relocation and Expansion of the New Beijiang Pharmaceutical Co., Ltd.” The “Project (Phase I)”, the “Lizhu Group Limin Pharmaceutical Factory Bagged Infusion Workshop Technical Improvement Project”, “Long-lasting Microsphere Technology R&D Platform Construction Project” and “Supplemental Liquidity and Bank Loan Repayment”) were completed, and the balance raised was 0.157 billion yuan (including interest income) to permanently supplement working capital (the actual amount is based on the bank account balance on the day the funds are transferred out). After the savings raised funds are transferred out, the special fund-raising account set up at the bank will no longer be used, and the company will complete the account sale procedure as soon as possible.
